19 security-"https:"-"https:"-"https:"-"https:"-"CUBO" positions at Center for Biologics Evaluation and Research (CBER)

FDA Studies on the Safety and Efficacy of Plasma-Derived Products and Their Recombinant Analogs

Center for Biologics Evaluation and Research (CBER) | United States | about 2 hours ago

*Applications will be reviewed on a rolling-basis. FDA Office and Location: A research opportunity is currently available at the Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA). in White Oak, Maryland. The Center for Biologics Evaluation and Research...

FDA Research Opportunity - Detection of Emerging Pathogens that Threaten Blood Safety

Center for Biologics Evaluation and Research (CBER) | Southern Md Facility, Maryland | United States | 3 days ago

-emerging transfusion-transmissible viruses (specifically hepatitis viruses) that threaten the safety of blood and blood-derived products. The project aims to advance in vitro models of infection and in vivo

FDA Fellowship - Immune Globulin Safety and Efficacy in Pregnant and Neonatal Populations

Center for Biologics Evaluation and Research (CBER) | Southern Md Facility, Maryland | United States | about 2 hours ago

safely, adhering to all the laboratory and personnel safety rules and regulations during appointment activities; Effectively communicate research findings using poster/oral presentations, and written

FDA Fellowship - Understanding the Role of the Manufacturing Microenvironment on the Safety and Efficacy of Cellular Therapies

Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | 4 days ago

the safety, purity, potency, and effectiveness of biological products including vaccines, blood and blood products, and cells, tissues, and gene therapies for the prevention, diagnosis, and treatment of human

FDA Fellowship - Developing Novel Strategies to Improve Safety, Efficacy and Quality of Gene Therapy Products

Center for Biologics Evaluation and Research (CBER) | Southern Md Facility, Maryland | United States | 4 days ago

applications (BLA) being submitted to the FDA, there is a need to develop innovative analytical methods and regulatory science approaches to comprehensively evaluate the safety, efficacy, and quality

FDA Non-clinical Identification and Mitigation of Safety Risks During the Development and Licensure of Protein-therapeutics

Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | 10 days ago

to understand the safety consequences of immune responses to neo-epitopes generated due to off-target gene editing. The following articles from our laboratory provide examples of research performed in our group

FDA Fellowship - Immune Globulin Safety and Efficacy in Pregnant and Neonatal Populations

Center for Biologics Evaluation and Research (CBER) | Southern Md Facility, Maryland | United States | 4 days ago

safely, adhering to all the laboratory and personnel safety rules and regulations during appointment activities; Effectively communicate research findings using poster/oral presentations, and written

FDA Computational and Experimental Assessment of Engineered Biotherapeutics: Safety and Regulatory Considerations of Synonymous Gene Recoding

Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | 4 days ago

Biol, 169718 (2026). https://doi.org:10.1016/j.jmb.2026.169718 Katneni, U.K., Liss, A., Holcomb, D., Katagiri, N., Hunt, R.C., Bar, H., Ismail, A., Komar, A.A. and Kimchi-Sarfaty, C.: Splicing

FDA Postdoctoral Fellowships in Cell and Gene Therapy

Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | 3 days ago

the regulation of biological and related products including blood, vaccines, allergenics, tissues, and cellular and gene therapies. Research Projects: Project Area 1: Cell and Gene Therapy Safety This project

FDA Postdoc - Investigating Host–Pathogen Interactions to Develop Next-Generation Sequencing-Based Assays for Comprehensive Microbial Surveillance in Biologics

Center for Biologics Evaluation and Research (CBER) | Southern Md Facility, Maryland | United States | about 1 hour ago

pathogens and adventitious agents, thereby improving product safety. This project aims to establish a comprehensive surveillance platform that combines Illumina short-read and PacBio HiFi long-read sequencing